Summary
Updated Aug 31, 2026
Jennifer A. Fox is Chief Business Officer and Chief Financial Officer of Zenas BioPharma, Inc. (ZBIO). 4 SEC Form 4 filings on record going back to 2024, most recently on 17 June 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Jennifer A. Fox has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jennifer A. Fox files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $133.53M of APGE open-market activity in the last 12 months
- Michael Thomas Henderson - $26.88M of APGE open-market activity in the last 12 months
- Nimish P. Shah - $15.00M of APGE open-market activity in the last 12 months
- Carl Dambkowski - $8.80M of APGE open-market activity in the last 12 months
- Hongbo Lu - $8.15M of ZBIO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jennifer A. Fox?
Jennifer A. Fox is a corporate insider, tracked as Chief Business Officer and Chief Financial Officer of Zenas BioPharma, Inc. (ZBIO). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jennifer A. Fox submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Jennifer A. Fox's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jennifer A. Fox and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
